CANDICE NEWMYER: Open Payments
NPI 1073122271 · EAST BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $152 · 2025 $858
Food & beverage: $858
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $303 |
| ABBVIE INC. | 9 | $212 |
| Lilly USA, LLC | 5 | $104 |
| Janssen Pharmaceuticals, Inc | 3 | $83 |
| Dexcom, Inc. | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| Exact Sciences Corporation | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: AIRSUPRA, SPRAVATO, QULIPTA, VRAYLAR, BREZTRI, MOUNJARO, LINZESS, Dexcom G6 Transmitter.
Industry payments across MA — which companies pay providers there.
